A phase I study of recombinant human interleukin-4 administered by the intravenous and subcutaneous route in patients with advanced cancer: immunological studies. [electronic resource]
Producer: 19931207Description: 205-11 p. digitalISSN:- 1148-5493
- Cell Division -- immunology
- Cytotoxicity, Immunologic -- physiology
- Humans
- Immunophenotyping
- Injections, Intravenous
- Injections, Subcutaneous
- Interleukin-2 -- pharmacology
- Interleukin-4 -- administration & dosage
- Leukocytes, Mononuclear -- drug effects
- Lymphocytes -- drug effects
- Mitogens -- pharmacology
- Neoplasms -- immunology
- Recombinant Proteins -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.